New Milford, CT, United States of America

Sabine Ruppel

USPTO Granted Patents = 4 


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sabine Ruppel

Introduction

Sabine Ruppel is a prominent inventor based in New Milford, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating inflammatory diseases. With a total of 4 patents to her name, her work is recognized for its potential impact on medical treatments.

Latest Patents

Ruppel's latest patents include innovative compounds such as substituted benzamides that act as RIPK2 inhibitors for the treatment of inflammatory bowel disease. The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R, R, X, Y, and HET are as defined in the patent documentation. Additionally, her work encompasses pharmaceutical compositions comprising these compounds, methods of using them in the treatment of various diseases and disorders, and processes for preparing these compounds and intermediates useful in these processes.

Career Highlights

Sabine Ruppel is currently employed at Boehringer Ingelheim International GmbH, where she continues to advance her research and development efforts. Her expertise in pharmaceutical sciences has positioned her as a key player in her field.

Collaborations

Ruppel has collaborated with notable colleagues, including Pingrong Liu and Craig Andrew Miller, to further enhance her research initiatives and drive innovation in pharmaceutical development.

Conclusion

Sabine Ruppel's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…